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Synchronous occurrence of different types of thyaroid carcinomas in the same gland is an unusual event. We report the case of simultaneous oca
currence of macroscopic papillary thyroid carcinoma 
(PTC) and medullary thyroid carcinoma (MTC) in a 
female patient with a longastanding multianodular goia
ter. In the histological examination, the thyroid gland 
showed a 4.5 cm MTC in the left lobe and a 2.5 cm 
PTC in the right lobe. Both tumours were clearly sepaa
rated from each other, representing the pure entity of 
each type. Postoperatively, RET protoaoncogene mutaa
tion was ruled out by sequence analysis of peripheral 
blood leukocytes. The clinical history of our patient is 
peculiar in two aspects: the large size of the PTC (2.5 
cm), which represents the largest PTC published so 
far in association with MTC and the unexpected indoa
lent benign clinical course of a longastanding and large 
MTC occurring in an elderly woman.
The simultaneous occurrence of PTC and MTC in 
the same thyroid gland is a rare condition that has been 
described in two main settings: a mixed tumor showing 
dual differentiation, the soacalled mixed medullary and 
follicular cell carcinoma; or a collision tumor, that is, 
two distinct and independent tumors separated by nora
mal thyroid tissue.1 This coincidence may postulate the 
possibility of a common cellular origin for both tumors. 
The ultimobranchial body has been suggested as the 
probable common origin.2 In addition, a potential cara
cinogenic agent common for both neoplasms has been 
proposed. Also, somatic mutations and gene rearrangea
ments in the RET protoaoncogene in MTC and PTC 
have been pointed to as a possible pathological nexus, 
explaining their simultaneous occurrence.3 We present 
the clinical and pathological peculiarities of two syna
chronous and independent thyroid tumors, and review 
the literature on the topic. We stress the unusual large 
size of the PTC and the long indolent benign clinical 
course of the case. The presence of germinal mutations 
in the RET protoaoncogene has been investigated.
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CASE 
Clinical findings
A 72ayearaold diabetic female with a long history of 
euthyroid multinodular goiter and on routine consultaa
tion for 25 years, presented at the last examination with 
a slow and progressive growth of her thyroid nodules, 
the largest one reaching 4.5 centimeter in diameter. 
Sonographic examination revealed two welladelimited 
nodular masses with peripheral calcifications (Figure 
1), which made fine needle aspiration cytology (FNAC) 
difficult to perform. The patient finally underwent a laa
borious total thyroidectomy due to local compressive 
symptoms. The surgical procedure did not include neck 
lymphadenectomy. Histopathological diagnosis of sia
multaneous PTC and MTC was established, and two 
months later, the patient received 100 mCi of sodium 
iodide I 131 with recombinant thyroid stimulating hora
mone (TSH, Thyrogen). The thyroglobulin (Tg) peak 
was 0.5 ng/mL, and the whole body scan showed ana
terior cervical uptake only. Five months after surgery, 
laboratory investigations showed a calcitonin level of 11 
ng/mL (normal, <12 ng/mL), a normal carcinoembrya
onic antigen (CEA) level, an undetectable Tg level after 
TSH administration, and negative antiaTg antibodies. 
Twelve months after surgery, basal calcitonin and CEA 
levels remained within normal limits. Analysis of the 
RET protoaoncogene by direct sequencing of exons 10, 
11, 13, 14, 15, and 16 revealed no point mutations.
Pathological findings
The surgical specimen weighted 123 g and showed two 
lobes measuring 13×8×8 cm on the right and 14×12×8 
cm on the left. Grossly, the cut surface was multinodua
lar. The left lobe was a 4.5acm tumor mass. The right 
lobe was a smaller highly calcified, multilobulated mass 
of 2.5 cm. Both tumors were well circumscribed but not 
encapsulated (Figure 2). 
Microscopically, the left lobe tumor (Figure 3) cona
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sisted of cells arranged in solid nests and trabecular 
structures that were immersed in abundant collagenous 
stroma, containing pools of amorphous and eosinophila
ic, amyloidalike material. Proliferating cells were round 
or polyhedral with large and finely granular eosinoa
philic cytoplasm and showed hyperchromatic nuclei. 
These cells were highly positive for chromogranin, syna
aptophysin, calcitonin and CEA, while negative for thya
roglobulin. Congo red staining confirmed the amyloid 
deposits in the stroma. The right lobe tumor (Figure 4) 
showed a papillary growth pattern, with abundant sclea
rotic stroma and shellalike calcifications. Papillae were 
lined by cuboidal cells with the typical nuclear criteria 
of papillary carcinoma (enlargement, overlapping, lona
gitudinal grooving and clear groundaglass chromatin). 
The immunohistochemical techniques showed positive 
immunostaining for thyroglobulin and CK19, while 
negative for all the rest.
DISCUSSION
In the 1988 edition of the WHO histological typing 
of thyroid tumors,1 mixed medullaryafollicular carcinoa
mas were defined as tumors showing the morphological 
and immunohistochemical features of MTC on the one 
hand, and a follicular cell carcinoma on the other. The 
description of cytological features of papillary carcinoa
ma within the follicular component was documented in 
1990 in two cases containing both cell types intimately 
admixed.4 
Several hypothesis have been postulated to explain 
the histogenesis of this coincidence including: a) the 
existence of common stem cells with a capacity to difa
ferentiate into both follicular and medullary lineages, 
b) the origin from C and follicular cells both originating 
from the ultimobranchial body, c) the development of 
PTC from MTC by way of a superaimposed mutation, 
or d) the simultaneous oncogenesis of both tumors. 
Somatic mutations in the RET protoaoncogene are 
associated with nonafamilial MTC, usually affecting 
exons 15 and 16 (more often in codon 918). Germinal 
mutations of RET preferably involve exons 10 and 11, 
and are indicative of familial MTC (the soacalled famila
ial MTC and multiple endocrine neoplasia [MEN]2). 
The rearrangement RET/PTC produces the fusion of 
the domain tyrosineakinase of the RET with sequence 
5’ of other genes and has been associated with 25% to 
40% of PTC, mainly in children and especially in radiaa
tionainduced tumors.5 The involvement of RET in both 
tumors and the finding of PTC in 9% of patients with 
MEN2 affected by mutations in exons 13 and 14 of the 
RET6 have suggested a possible role of these germinal 
mutations in the development of PTC in addition to 
Figure 1. Neck sonographic examination revealed two well-
delimited nodular masses with peripheral calcifications: one of 
4.5 cm in the left lobe and the other of 2.5 cm in the right lobe.
Figure 2. Macroscopic view of two intraglandular tumour masses: L) Left lobe revealed 
a 4.5 cm solid tumour mass. R) Right lobe presented a smaller multilobulated mass of 2.5 
cm.
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the already wellaknown influence in MTC.6 However, 
immunohistochemical and in situ hybridization studa
ies have proven a different origin of both cellular lines, 
further evidenced by the nonaconcurrent expression of 
calcitonin and thyroglobulin genes in both cell types.7 
Besides, the somatic genetic analysis of both MTC and 
PTC has evidenced different mutation patterns,8 which 
strongly speaks against the common cellular progenia
tor theory. The genetic analysis of familial MTC with 
germinal mutations in RET has not evidenced any reara
rangement or somatic mutation of RET in simultanea
ous PTC.3 On the other hand, an RET somatic mutaa
tion has been detected only in the MTC in a mixed case 
with sporadic MTC and PTC, while an activating mua
tation in the BRAF gene was found in PTC without the 
RET/PTC rearrangement.9 As previously reported,10 
the activating mutation in the BRAF gene is associated 
with more than 50% of PTC. 
Our patient had two tumors separated by normal 
thyroid tissue which is very rarely reported in the lita
Figure 3. Microscopic view showing the medullary thyroid 
carcinoma: A) polyhedral cells with large and finely granular 
eosinophilic cytoplasm, arranged in solid nests and trabecular 
structures, immersed in abundant collagenous stroma containing 
pools of amyloid-like material. B) Proliferating cells are highly 
positive for chromogranin.
Figure 4. Microscopic view showing the papillary thyroid 
carcinoma: A) papillary pattern, with abundant sclerotic stroma, 
and shell-like calcifications. Papillae are lined by cuboidal cells 
with nuclear enlargement, overlapping, longitudinal grooving, 
and clear ground-glass chromatin. B) Proliferating cells are 
highly positive for CK19.
erature, with only 20 cases collected in two recent 
reviews.9,11 The incidental finding of papillary microa
carcinoma in thyroidectomy specimens from patients 
with germinal mutations in codons 790, 791, and 804 
of RET occurs in almost 10% of the reported cases.2,6 
In our case, the genetic analysis of RET ruled out the 
possibility of familial MTC with associated incidena
tal PTC. The present case calls attention to the size of 
the PTC (2.5 cm), which represents the largest PTC 
published so far in association with MTC. Also, the una
expected indolent and benign clinical course of a longa
standing and large MTC occurring in an elderly woman 
is quite surprising.
A recent study demonstrates the predictive value of 
preoperative calcitonin levels in the survival of MTC,13 
and the influence of lymph node involvement in its 
prognosis.14 For this reason, some authors advise quana
tifying calcitonin levels preoperatively.15 The peculiar 
clinical presentation of our case, with asymptomatic 
and clinically unsuspected neoplasm in the context of 
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a longastanding nodular goiter that was removed only 
because of local compressive symptoms, made the lack 
of neck lymph node dissection and lack of preoperative 
calcitonin determination understandable. 
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